Oragenics Reports COVID-19 Challenge Study Results Evaluating Multiple Formulations Of Its SARS-CoV-2 Vaccine Candidate: ‘Both formulations [in hamster model] generated robust immune responses and reduced the SARS-CoV-2 viral loads’

by | Dec 1, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.